1-3 of 3
Thomas Blankenstein, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD40L + CD8 + T-Cell Dependent Antitumor Immunity

Andreas Thiel, PhD, Marco Frentsch, Joanna Listopad, Regina Stark, Alberto Sada Japp, Nadine Matzmohr, Sarah Meier, Ichiro Taniuchi, MD PhD, Thomas Blankenstein, PhD
Journal: Blood
Blood (2014) 124 (21): 5818.
https://doi.org/10.1182/blood.V124.21.5818.5818
Published: 2014
Journal Articles

Stromal Cross-Presentation and Host Interferon-γ Signaling and Are Required for Elimination of Antigen-Loss Variants of High-Grade B Cell Lymphomas: Implications for Adoptive T Cell Therapy

Armin Gerbitz, MD, PhD, Madhusudhanan Sukumar, PhD, Florian Helm, Andrea Wilke, Christian Friese, Cornelia Fahrenwaldt, Frank Lehmann, Christoph Loddenkemper, MD, PhD, Thomas Kammertöns, PhD, Josef Mautner, PhD, Thomas Blankenstein, PhD, Georg Bornkamm, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3927.
https://doi.org/10.1182/blood.V116.21.3927.3927
Published: 2010
Journal Articles

Redirecting Human T Lymphocytes toward Tumor-Associated Antigens by T Cell Receptor (TCR) Replacement.

Julia Neudorfer, Daniel Sommermeyer, Christian Peschel, MD, Thomas Blankenstein, PhD, Wolfgang Uckert, PhD, Helga Bernhard, MD
Journal: Blood
Blood (2006) 108 (11): 3711.
https://doi.org/10.1182/blood.V108.11.3711.3711
Published: 2006